📉 A major market shock is expected on Monday due to the buyback blackout period beginning, which historically leads to a decline in stock prices.
💲 Corporate stock buybacks have been the major driver of equity purchases, with authorization reaching 789 billion dollars year to date.
📊 Goldman predicts a 30 to 50 percent decline in trading volume during the blackout period, signaling a significant impact on the market.
💡 Negative sentiment and positioning indicate a major market shock is expected.
⚠️ Machines' positioning in US and global equities suggest a downward trend.
📉 Technical signals show a potential decrease in momentum.
📊 The S&P is showing signs of a lower high, indicating a potential downside move.
💻 Momentum in the tech sector is slowing down and rolling over, with concerns about tech companies buying back stocks.
📉 The QQQ is also showing signs of a lower high, suggesting a possible market decline.
💼 TLT momentum is negative, with a consecutive daily sell signal, suggesting a downward trend.
📈 On the upside, adding another position on TLT when it moves off the Max short is recommended with a target of 97.25.
🔍 Gold is forming a massive topping pattern, indicating it's more likely to be sold than bought.
📈 The 100-day moving average indicates a topping pattern, suggesting people are selling.
📉 GDX shows signs of a topping pattern, with sellers waiting for buyers to come in.
⚠️ There is a potential major buying opportunity if GDX drops to around 18.
📉 Silver is likely to break down, with negative momentum and consecutive sell signals.
📉 SLV has a topping pattern, with sellers above and a potential target of 18.
📈 Momentum is positive for King Joller, suggesting it is overbought.
🔎 The Invesco dollar bearish fund (UDN) shows potential for a reversal in the dollar's downward trend.
💰 The Platinum trade demonstrates multiple buying opportunities and the potential for a positive return.
💁 Mira Pharmaceuticals (MIRA) is a promising stock with the potential for a significant upside movement.
📈 The stock of Mira 1A has experienced a massive wave of selling and is now considered massively oversold.
💊 Mira 1A is a prescription medication being developed with a better side effect profile and is focused on three therapeutic areas: neuropathic pain, anxiety, and cognitive decline.
🔬 Mira 1A has demonstrated its ability to enhance memory, improve cognitive performance, reduce pain, and relieve anxiety in pre-clinical research.
How to Build a No-code AI Chatbot in Zapier
Four free AI tools for creating stunning presentations | Automation the presentation using latest AI
William Hughes. Neoliberalismo, pandemia y economía
How To Find Your Perfect Partner
NAPO | *Award-Winning* Animated Short Film
Estás en primera fila para conocer al nuevo Galaxy S23 Ultra